Regulatory Developments: Following months of litigation and policy changes, the regulatory framework for compounded tirzepatide has evolved, which affects what options may be available and at what cost
Conditions such as Crohn's disease, pernicious anemia, or a history of gastric surgery may increase the risk of B12 deficiency
Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages
The most common adverse effects are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and abdominal pain
Retatrutide is an investigational once-weekly injectable medicine studied for obesity and metabolic conditions
GLP-1 medications are not magic bullets - they require sustained commitment